GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kane Biotech KNE.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.03

0.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Kane Biotech — daily TSXV:KNE Delayed
Market value
C$5.4m
Last close × shares
Volume
50.9k
Shares, 9 Nov 2026

About Kane Biotech

Its shares trade on TSX Venture under the ticker KNE.V. It has been listed since 7 May 2003. In the fiscal year to 31 December 2025, it reported revenue of C$427,869 and a net loss of C$2.7m. At that date it held total assets of C$2.7m and shareholders' equity of −C$746,545.

Kane Biotech, Inc. is a biotechnology company, which engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. The company is headquartered in Winnipeg, Manitoba. The company went IPO on 2003-05-07. The firm is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. The company also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.

Figures and description from our data supplier, not checked against the company's own report.

More about Kane Biotech →

Latest on Kane Biotech

Our reporting

We have not reported on Kane Biotech yet.

Next results

26 Nov 2026

Due on 26 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Kane Biotech's ticker?

Kane Biotech trades as KNE.V on TSX Venture, under ISIN CA4838092084.

What was Kane Biotech's last closing price?

0.03 on 9 Nov 2026. The figure is in CAD and is never converted.

When does Kane Biotech next report results?

Results are expected on 26 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.